Notably, the high expression level of NEIL3 was significantly related to shorter DFI in most cancers (Figure S4A–G,I), while it was the opposite in stomach adenocarcinoma (STAD) (Figure S4H). This evidence concerns the gene NEIL3 and gastric adenocarcinoma.